A 32-year-old primigravida at 39 weeks gestation with an unfavorable cervix (Bishop score 6) requires labor induction for gestational diabetes. Which feature best distinguishes the use of misoprostol from dinoprostone in this clinical scenario?

Explanation

## Comparison: Misoprostol vs Dinoprostone for Labor Induction ### Key Distinguishing Features **Key Point:** The most clinically relevant discriminator between misoprostol and dinoprostone is the **route of administration and dosing flexibility** of misoprostol. | Feature | Misoprostol | Dinoprostone | |---------|-------------|-------------| | **Routes** | Vaginal, oral, sublingual, buccal | Vaginal (gel) or intracervical (insert) | | **Storage** | Room temperature, stable | Requires refrigeration (2–8°C) | | **Shelf life** | 3–5 years | 18 months (refrigerated) | | **Dosing flexibility** | Multiple routes allow titration | Fixed-dose formulations | | **Cost** | Inexpensive (~₹10–20 per dose) | Expensive (~₹1500–2500 per dose) | | **Uterine tachysystole risk** | ~5–10% | ~5–10% | | **Systemic side effects** | Mild (fever, diarrhea) | Mild (fever, nausea) | ### Clinical Advantages of Misoprostol 1. **Versatile routes:** Vaginal (most common in India), oral, or sublingual dosing allows individualization based on cervical ripeness and patient tolerance. 2. **Stability:** Room-temperature storage eliminates cold-chain dependency—critical in resource-limited settings. 3. **Cost-effectiveness:** Makes it the preferred agent in Indian public health systems. 4. **Dose titration:** Can be given at 25 µg intervals vaginally every 3–6 hours, or 25 µg orally every 2 hours. ### Why Dinoprostone? Dinoprostone is reserved for settings where: - Misoprostol is contraindicated (rare). - Refrigeration is reliably available. - Cost is not a limiting factor. **High-Yield:** In NEET PG exams, misoprostol is the **first-line cervical ripening agent** in India due to cost, stability, and route flexibility—not because dinoprostone is ineffective. **Clinical Pearl:** Both agents carry a ~5–10% risk of uterine tachysystole; neither is absolutely contraindicated after prior cesarean, though both require vigilant fetal monitoring. Oxytocin is safer post-cesarean. [cite:Park 26e Ch 3] [cite:FIGO Guidelines on Labor Induction]